LYVE1 and cancer: The splenic immunophenotye of mice with advanced cancer showed the emergence of the hyaluronic acid receptor CD44+ and in a smaller extent IL-17A+ MDSCs, the loss of B220+ and CD62L+ B-cells, the loss of CD62L+ CD4+ and CD8+T-cells (Figure 5, Figure 6 and Figure 7).